Cellebrite DI (NASDAQ:CLBT) vs. MariaDB (NYSE:MRDB) Head-To-Head Review

MariaDB (NYSE:MRDB) and Cellebrite DI (NASDAQ:CLBT) are both computer and technology companies, but which is the superior business? We will compare the two businesses based on the strength of their profitability, valuation, risk, institutional ownership, earnings, analyst recommendations and dividends.

Analyst Recommendations

This is a breakdown of recent ratings and recommmendations for MariaDB and Cellebrite DI, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
MariaDB	0	0	0	0	N/A
Cellebrite DI	0	0	6	0	3.00

Cellebrite DI has a consensus target price of $13.17, suggesting a potential upside of 10.18%. Given Cellebrite DI’s higher probable upside, analysts clearly believe Cellebrite DI is more favorable than MariaDB.

Institutional & Insider Ownership

30.7% of MariaDB shares are owned by institutional investors. Comparatively, 45.9% of Cellebrite DI shares are owned by institutional investors. 26.1% of MariaDB shares are owned by insiders. Comparatively, 5.7% of Cellebrite DI shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Profitability

This table compares MariaDB and Cellebrite DI’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
MariaDB	-73.29%	N/A	-121.43%
Cellebrite DI	-32.57%	417.94%	13.40%

Volatility & Risk

MariaDB has a beta of 0.62, meaning that its share price is 38% less volatile than the S&P 500. Comparatively, Cellebrite DI has a beta of 1.48, meaning that its share price is 48% more volatile than the S&P 500.

Valuation & Earnings

This table compares MariaDB and Cellebrite DI’s gross revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
MariaDB	$53.11 million	0.69	-$51.86 million	($0.59)	-0.90
Cellebrite DI	$325.11 million	7.57	-$81.10 million	($0.58)	-20.60

MariaDB has higher earnings, but lower revenue than Cellebrite DI. Cellebrite DI is trading at a lower price-to-earnings ratio than MariaDB, indicating that it is currently the more affordable of the two stocks.

Summary

Cellebrite DI beats MariaDB on 10 of the 13 factors compared between the two stocks.

About MariaDB

MariaDB plc operates as a cloud database company in North and South America, Europe, the Middle East, Africa, and the Asia Pacific. It offers database solutions, including MariaDB Enterprise Server, a premium version of community server; MariaDB Xpand, a distributed structured query language (SQL) database for transactional workloads; MariaDB ColumnStore for data warehousing; MariaDB MaxScale for availability and load balancing; and MariaDB SkySQL, a database-as-a-service for its products on public clouds. The company also provides consulting, training, remote database administration, and engineering architecture services. It serves financial services, government, technology, retail, telecommunications, and transportation industries. The company is headquartered in Redwood City, California.

About Cellebrite DI

Cellebrite DI Ltd. develops solutions for legally sanctioned investigations in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. The company's DI suite of solutions allows users to collect, review, analyze, and manage digital data across the investigative lifecycle with respect to legally sanctioned investigations used in various cases, including child exploitation, homicide, anti-terror, border control, sexual crimes, human trafficking, corporate security, cryptocurrency, and intellectual property theft. It provides Inseyets, a digital forensics software that collects and reviews digital evidence from various digital sources when conducting legally sanctioned investigations. The company's digital forensics software also offers data extraction, decoding capabilities, workflows, and automation capabilities. In addition, it provides Cellebrite Pathfinder, which reduces the time spent manually reviewing digital evidence by automating data analysis and visualization; Smart Search, an open source intelligence tool that automates the collection and review of publicly available online data; and Guardian, a case and evidence management solution. Further, the company offers digital forensic software for enterprises and service providers, including Inseyets for Enterprise, Endpoint Inspector, and Mobile Now; and professional services, such as training and certification services, and other services. It serves federal and state and local agencies. The company was incorporated in 1999 and is headquartered in Petah Tikva, Israel.